IP Library › Assignment 026195/0312
Patent Assignment
Reel/Frame 026195/0312

Assignment of Assignor's Interest

Recorded: 2011-04-28 Pages: 3
Assignor
NOVARTIS AG
Executed: 2011-04-27
Assignee
Covered Properties (3)
Immunotoxin with in Vivo T Cell Suppressant Activity and Methods of Use
Patent: 7,517,527 →
Application: 09/389,565 →
Publication: US 2003/0157093
Immunotoxin Fusion Proteins and Means for Expression Thereof
Patent: 7,696,338 →
Application: 10/296,085 →
Publication: US 2004/0127682
Immunotoxin Fusion Proteins and Means for Expression Thereof
Patent: 8,217,158 →
Application: 12/718,673 →
Publication: US 2011/0086416
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 16, 2002
From: HEXHAM, JONATHAN MARK; DIGAN, MARY ELLEN
To: NOVARTIS AG
Reel/Frame 013586/0460 →
Assignment of Assignor's Interest Dec 16, 2002
From: NEVILLE JR., DAVID M.; THOMPSON, JERRY T.; HU, HUAIZHONG; WOO, JUNG-HEE
To: HEALTH AND HUMAN SERVICES, THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF
Reel/Frame 013586/0971 →
Assignment of Assignor's Interest Mar 30, 2011
From: NOVARTIS AG
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE DEPARTMENT OF HEALTH & HUMAN SERVICES, NATIONAL INSTITUTE OF HEALTH, OFFICE OF TECHNOLOGY TRANSFER
Reel/Frame 026051/0917 →
Assignment of Assignor's Interest Aug 27, 2021
From: HU, HUAIZHONG; MA, SHENGLIN; THOMPSON, JERRY T.; WOO, JUNG-HEE
To: THE USA, AS REPRESENTED BY THE SECRETARY, DEPT OF HEALTH AND HUMAN SERVICES
Reel/Frame 057307/0844 →